More than half of patients with advanced cancer have difficulty breathing, and this chronic dyspnea can be highly debilitating and challenging to manage, thanks to the lack of evidence-based treatment ...

ORLANDO, FL — The oral vasopressin-2 receptor antagonist tolvaptan (Samsca, Otsuka American Pharmaceutical) indeed promotes significant loss of fluid volume in patients with acute decompensated heart ...

Population-based prospective cohort study of psychosocial factors and survival of young Australian women with breast cancer No significant financial relationships to disclose. This is an ASCO Meeting ...

Safety and Efficacy of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group Our search yielded 18 trials. Fourteen ...

Based on responses from 178 providers, the researchers found that most providers (77 percent) agree that dyspnea relief is an important goal when treating patients with cardiopulmonary conditions. The ...

When to begin maintenance therapy for patients with chronic obstructive pulmonary disease (COPD) with either a single drug, or a combination of long-acting bronchodilators, is not always clear. A new ...

Treatment with serelaxin, a recombinant human relaxin-2 vasoactive peptide hormone, resulted in dyspnea relief and other clinical improvements but had no effect on hospital readmission, according to ...

What Is Dyspnoea And What Are Its Causes? Before we delve deep into dyspnoea, let us explain what it actually is. “Dyspnoea is a feeling of difficult or uncomfortable breathing, often described as ...

The natriuretic peptides, specifically brain natriuretic peptide (BNP), are the most specific and applicable laboratory tests available to establish fluid overload associated with HF. 9 BNP is ...

Please provide your email address to receive an email when new articles are posted on . Patients with recently diagnosed HF had greater early dyspnea relief and improved survival after hospital ...

(HealthDay News) — The majority of hospitalists believe that routinely assessing dyspnea severity would enhance their clinical decision making and positively affect patient care, according to a study ...